Trabajos de Manuel Ruiz-Borrego

Trabajos de Nombre

Clinical Medicine


  Listando 16 trabajos del autor/autora 38
Lista de trabajos en el área Clinical Medicine
Mentions   0   Wikipedia   50   News   0   Policy
Article 21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer Kalinsky, Kevin; Barlow, William E.; Gralow, Julie R.; Meric-Bernstam, Funda; Albain, Kathy S.; Hayes, Daniel F.; Lin, Nancy U.; Perez, Edith A.; Goldstein, Lori J.; Chia, Stephen K. L.; Dhesy-Thind, Sukhbinder; Rastogi, Priya; Alba, Emilio; Delaloge, Suze NEW ENGLAND JOURNAL OF MEDICINE 0028-4793 (2021) DOI / 10.1056/nejmoa2108873
Mentions   0   Wikipedia   47   News   0   Policy
Article Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial Chan, Arlene; Moy, Beverly; Mansi, Janine; Ejlertsen, Bent; Holmes, Frankie Ann; Chia, Stephen; Iwata, Hiroji; Gnant, Michael; Loibl, Sibylle; Barrios, Carlos H.; Somali, Isil; Smichkoska, Snezhana; Martinez, Noelia; Alonso, Mirta Garcia; Link, John S.; Ma CLINICAL BREAST CANCER 1526-8209 (2021) DOI / 10.1016/j.clbc.2020.09.014 Green published, Gold other
Mentions   0   Wikipedia   6   News   0   Policy
Article Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01) Lluch, Ana; Barrios, Carlos H.; Torrecillas, Laura; Ruiz-Borrego, Manuel; Bines, Jose; Segalla, Jose; Guerrero-Zotano, Angel; Garcia-Saenz, Jose A.; Torres, Roberto; de la Haba, Juan; Garcia-Martinez, Elena; Gomez, Henry L.; Llombart, Antonio; Salvador Bof JOURNAL OF CLINICAL ONCOLOGY 0732-183X (2020) DOI / 10.1200/jco.19.00904 Gold other
Mentions   0   Wikipedia   1   News   0   Policy
Article Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study Rugo, Hope S.; Lerebours, Florence; Ciruelos, Eva; Drullinsky, Pamela; Ruiz-Borrego, Manuel; Neven, Patrick; Park, Yeon Hee; Prat, Aleix; Bachelot, Thomas; Juric, Dejan; Turner, Nicholas; Sophos, Nickolas; Zarate, Juan Pablo; Arce, Christina; Shen, Yu-ming LANCET ONCOLOGY 1470-2045 (2021) DOI / 10.1016/s1470-2045(21)00034-6
Mentions   0   Wikipedia   4   News   0   Policy
Article Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial-PEARL Martin, M.; Zielinski, C.; Ruiz-Borrego, M.; Carrasco, E.; Turner, N.; Ciruelos, E. M.; Munoz, M.; Bermejo, B.; Margeli, M.; Anton, A.; Kahan, Z.; Csoszi, T.; Casas, M., I; Murillo, L.; Morales, S.; Alba, E.; Gal-Yam, E.; Guerrero-Zotano, A.; Calvo, L.; de ANNALS OF ONCOLOGY 0923-7534 (2021) DOI / 10.1016/j.annonc.2020.12.013 Green published, Gold other
Mentions   0   Wikipedia   3   News   0   Policy
Article Original Research Health-related quality of life with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive metastatic breast cancer: Patient-reported outcomes in the PEARL study Kahan, Zsuzsanna; Gil-Gil, Miguel; Ruiz-Borrego, Manuel; Carrasco, Eva; Ciruelos, Eva; Munoz, Montserrat; Bermejo, Begona; Margeli, Mireia; Anton, Antonio; Casas, Maribel; Csoszi, Tibor; Murillo, Laura; Morales, Serafin; Calvo, Lourdes; Lang, Istvan; Alba, EUROPEAN JOURNAL OF CANCER 0959-8049 (2021) DOI / 10.1016/j.ejca.2021.07.004 Hybrid
Mentions   0   Wikipedia   2   News   0   Policy
Article Paclitaxel With Inhibitor of Apoptosis Antagonist, LCL161, for Localized Triple-Negative Breast Cancer, Prospectively Stratified by Gene Signature in a Biomarker-Driven Neoadjuvant Trial Bardia, Aditya; Parton, Marina; Kuemmel, Sherko; Estevez, Laura G.; Huang, Chiun-Sheng; Cortes, Javier; Ruiz-Borrego, Manuel; Telli, Melinda L.; Martin-Martorell, Paloma; Lopez, Rafael; Beck, J. Thaddeus; Ismail-Khan, Roohi; Chen, Shin-Cheh; Hurvitz, Sara JOURNAL OF CLINICAL ONCOLOGY 0732-183X (2018) DOI / 10.1200/jco.2017.74.8392
Mentions   0   Wikipedia   1   News   0   Policy
Article Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: the CONTROL trial Barcenas, C. H.; Hurvitz, S. A.; Di Palma, J. A.; Bose, R.; Chien, A. J.; Iannotti, N.; Marx, G.; Brufsky, A.; Litvak, A.; Ibrahim, E.; Alvarez, R. H.; Ruiz-Borrego, M.; Chan, N.; Manalo, Y.; Kellum, A.; Trudeau, M.; Thirlwell, M.; Saenz, J. Garcia; Hunt, ANNALS OF ONCOLOGY 0923-7534 (2020) DOI / 10.1016/j.annonc.2020.05.012 Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Article Palbociclib combined with endocrine therapy in heavily pretreated HR+/HER2(-) advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP) Manso, Luis; Hernando, Cristina; Galan, Maria; Oliveira, Mafalda; Cabrera, Miguel A.; Bratos, Raquel; Rodriguez, Cesar A.; Ruiz-Borrego, Manuel; Blanch, Salvador; Llombart-Cussac, Antonio; Delgado-Mingorance, Juan I.; Alvarez-Busto, Inaki; Gallegos, Isabel BREAST 0960-9776 (2020) DOI / 10.1016/j.breast.2020.11.005 Gold DOAJ, Green published
Mentions   0   Wikipedia   1   News   0   Policy
Article A retrospective, multicenter study of the efficacy of lapatinib plus trastuzumab in HER2-positive metastatic breast cancer patients previously treated with trastuzumab, lapatinib, or both: the Trastyvere study Gavila, J.; de la Haba, J.; Bermejo, B.; Rodriguez-Lescure, A.; Anton, A.; Ciruelos, E.; Brunet, J.; Munoz-Couselo, E.; Santisteban, M.; Rodriguez Sanchez, C. A.; Santaballa, A.; Sanchez Rovira, P.; Garcia Saenz, J. A.; Ruiz-Borrego, M.; Guerrero-Zotano, A CLINICAL & TRANSLATIONAL ONCOLOGY 1699-048X (2020) DOI / 10.1007/s12094-019-02145-4
Mentions   0   Wikipedia   0   News   1   Policy
Article Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice Blancas, I.; Fontanillas, M.; Conde, V.; Lao, J.; Martinez, E.; Sotelo, M. J.; Jaen, A.; Bayo, J. L.; Carabantes, F.; Illarramendi, J. J.; Gordon, M. M.; Cruz, J.; Garcia-Palomo, A.; Mendiola, C.; Perez-Ruiz, E.; Bofill, J. S.; Baena-Canada, J. M.; Janez, CLINICAL & TRANSLATIONAL ONCOLOGY 1699-048X (2018) DOI / 10.1007/s12094-017-1797-9
Mentions   0   Wikipedia   0   News   0   Policy
Article Efficacy and safety of dasatinib with trastuzumab and paclitaxel in first line HER2-positive metastatic breast cancer: results from the phase II GEICAM/2010-04 study Ocana, Alberto; Gil-Martin, Marta; Antolin, Silvia; Atienza, Maria; Montano, Alvaro; Ribelles, Nuria; Urruticoechea, Ander; Falcon, Alejandro; Pernas, Sonia; Orlando, Javier; Carlos Montero, Juan; Jose Escudero, Maria; Benito, Sara; Caballero, Rosalia; Car BREAST CANCER RESEARCH AND TREATMENT 0167-6806 (2019) DOI / 10.1007/s10549-018-05100-z
Mentions   0   Wikipedia   0   News   0   Policy
Review Contextualizing pertuzumab approval in the treatment of HER2-positive breast cancer patients Cortes, Javier; Ciruelos, Eva.; Perez-Garcia, Jose; Albanell, Joan; Garcia-Estevez, Laura; Ruiz-Borrego, Manuel; Espinosa, Ruth; Gallegos, Isabel; Gonzalez, Santiago; Alvarez, Isabel; Llombart, Antonio CANCER TREATMENT REVIEWS 0305-7372 (2020) DOI / 10.1016/j.ctrv.2019.101944
Mentions   0   Wikipedia   0   News   0   Policy
Article Outcomes of single versus double hormone receptor-positive breast cancer. A GEICAM/9906 sub-study Ethier, J. L.; Ocana, A.; Rodriguez Lescure, A.; Ruiz, A.; Alba, E.; Calvo, L.; Ruiz-Borrego, M.; Santaballa, A.; Rodriguez, C. A.; Crespo, C.; Ramos, M.; Gracia Marco, J.; Lluch, A.; Alvarez, I.; Casas, M.; Sanchez-Arago, M.; Carrasco, E.; Caballero, R.; EUROPEAN JOURNAL OF CANCER 0959-8049 (2018) DOI / 10.1016/j.ejca.2018.02.018
Mentions   0   Wikipedia   0   News   0   Policy
Article Prognostic role for the derived neutrophil-to-lymphocyte ratio in early breast cancer: a GEICAM/9906 substudy Templeton, A. J.; Rodriguez-Lescure, A.; Ruiz, A.; Alba, E.; Calvo, L.; Ruiz-Borrego, M.; Santaballa, A.; Rodriguez, C. A.; Crespo, C.; Ramos, M.; Gracia-Marco, J. M.; Lluch, A.; Alvarez, I.; Casas, M. I.; Sanchez-Arago, M.; Caballero, R.; Carrasco, E.; Am CLINICAL & TRANSLATIONAL ONCOLOGY 1699-048X (2018) DOI / 10.1007/s12094-018-1885-5
Mentions   0   Wikipedia   0   News   0   Policy
Article Phase III evaluating the addition of fulvestrant (F) to anastrozole (A) as adjuvant therapy in postmenopausal women with hormone receptor-positive HER2-negative (HR+/HER2-) early breast cancer (EBC): results from the GEICAM/2006-10 study Ruiz-Borrego, Manuel; Guerrero-Zotano, Angel; Bermejo, Begona; Ramos, Manuel; Cruz, Josefina; Manuel Baena-Canada, Jose; Cirauqui, Beatriz; Rodriguez-Lescure, Alvaro; Alba, Emilio; Martinez-Janez, Noelia; Munoz, Montserrat; Antolin, Silvia; Alvarez, Isabel BREAST CANCER RESEARCH AND TREATMENT 0167-6806 (2019) DOI / 10.1007/s10549-019-05296-8